Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report

By sjmartinez • June 4, 2024

Lam K, Gates GA, Bach DQ, Cheng K. Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report. Case Rep Dermatol. 2024 May 28;16(1):133-139. doi: 10.1159/000539058. PMID: 38831934; PMCID: PMC11147515.

Tags: binimetinib, BRAF inhibitor, BRAF V600E, Case report, Cetuximab, Dermatology, EGFR inhibitor, Encorafenib, Eruptive melanocytic nevi, MEK inhibitor, Publications

Inpatient Management of Hidradenitis Suppurativa: A Single-Center Retrospective Study

Bermudez NM, Yaghi M, Elman M SA, Kirsner RS, Lev-Tov H. Inpatient Management of Hidradenitis Suppurativa: A Single-Center Retrospective Study. J Am Acad Dermatol. 2025[...]

Isolated Lesion of Penile Kaposi Sarcoma in an HIV-Negative Male Patient

Eeraveni A, Gates G, Singh A, Ahronowitz I. Isolated Lesion of Penile Kaposi Sarcoma in an HIV-Negative Male Patient. Cureus. 2025 Jul 21;17(7):e88451. doi: 10.7759/cureus.88451.[...]

Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence

Chan AA, Noguti J, Ramirez NM, Navarrete M, Lee DJ. Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence. J Invest Dermatol. 2025[...]